Abbott Receives FDA Approval for TriClip™, First-of-i

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's first-of-its-kind TriClip™ transcatheter edge-to-edge repair (TEER) system that's specifically designed for the treatment of tricuspid regurgitation (TR), or a leaky tricuspid valve. This approval follows ...

Related Keywords

Canada , Amplatzer Piccolo , Dhaval Elmariah , Sandra Lesenfants , Lynnc Headrick , Amplatzer Piccolo Occluder , Paul Sorajja , Facebook , Youtube , Drug Administration , Minneapolis Heart Institute Foundation , Instagram , Linkedin , Valve Science Center , Circulatory System Devices Panel , Medical Devices Advisory Committee , Multichannel News Release , Family Chair , Structural Heart Disease , Minneapolis Heart Institute , Abbott Northwestern Hospital ,